Stroke neuroprotection trial pulled before it started

NCT ID NCT05032781

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This was a very early (Phase 1) study that planned to give a mixture of cold saline, minocycline, and magnesium directly into the brain's arteries right after a stroke procedure to reopen blocked vessels. The goal was to see if this cocktail could safely protect brain tissue and improve recovery. However, the trial was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cold saline, minocycline, and magnesium sulfate
What this could lead to
If this approach had been tested and worked, it could point toward a way to protect brain tissue during stroke treatment, potentially reducing long-term disability.
What could go wrong
This trial was withdrawn before any participants were enrolled, so no data is available. Even if tested, it was an early Phase 1 safety study, and the combination might not have improved outcomes or could have caused harm like bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO LARGE VESSEL OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • North Shore University Hospital

    Manhasset, New York, 11030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.